Ann: Regeneus and AGC collaborate on Progenza in Japan, page-46

I think we also have to seperate the TA from the FA.

TA is telling us that resistance is at 18c and everybody sees that and is thinking that.

But the details of the announcement yesterday greatly improve the FA beyond what most people thought they could arrange when expecting this deal to be done. I think everyone is thinking aling the TA lines which is fine short term but when the TA catches up with the FA then she will run hard.

I will be interested to see the details of the CYP deal with Fuji and then to compare MCs and details. The arrangement RGS have organised here is very good for this size biotech imo.